IZEA director granted 4,274 restricted shares

Caron John H reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Caron John H reported acquisition or exercise transactions in this Form 4 filing.

IZEA Worldwide, Inc. director John H. Caron received a grant of 4,274 shares of restricted common stock as Q1 2026 director fees. The award was valued at $15,000, based on a closing market price of $3.5100 per share on March 31, 2026, and it vested immediately on the grant date. Following this grant, Caron directly holds 106,415 shares of common stock and indirectly holds 5,000 shares through the John H. Caron 1999 Family Trust, where he has both voting and investment power.

Insider Trade Summary 10b5-1

Grant/Award: 4,274 shares

Grant/Award 2 txns

Insider Caron John H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,274	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 106,415 shares (Direct); Common Stock — 5,000 shares (Indirect, By John H. Caron 1999 Family Trust)

Footnotes (2)

F1. Restricted Stock received for Q1 2026 director fees valued at $15,000 based on the closing market price of $3.5100 on the grant date of March 31, 2026. Award vests immediately at the grant date.
F2. John H. Caron, as trustee, has voting power and investment power over the securities held by the John H. Caron 1999 Family Trust.

Key Figures

Restricted shares granted: 4,274 shares Grant value: $15,000 Reference share price: $3.5100 per share +2 more

5 metrics

Restricted shares granted 4,274 shares Q1 2026 director fees grant on March 31, 2026

Grant value $15,000 Value of restricted stock for Q1 2026 director fees

Reference share price $3.5100 per share Closing market price on March 31, 2026 used for valuation

Direct holdings after grant 106,415 shares Common stock directly held by John H. Caron after transaction

Indirect holdings 5,000 shares Common stock held by John H. Caron 1999 Family Trust

Key Terms

Restricted Stock, director fees, closing market price, vests immediately, +1 more

5 terms

Restricted Stock financial

"Restricted Stock received for Q1 2026 director fees valued at $15,000"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

director fees financial

"Restricted Stock received for Q1 2026 director fees valued at $15,000"

closing market price financial

"valued at $15,000 based on the closing market price of $3.5100"

vests immediately financial

"Award vests immediately at the grant date."

Family Trust financial

"held by the John H. Caron 1999 Family Trust."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IZEA (IZEA) director John H. Caron report?

John H. Caron reported receiving 4,274 shares of IZEA common stock as a restricted stock grant for Q1 2026 director fees. This grant was compensation, not an open-market purchase or sale, and was reported on a Form 4 insider trading filing.

How was John H. Caron’s IZEA (IZEA) restricted stock grant valued?

The restricted stock grant to John H. Caron was valued at $15,000, based on IZEA’s closing market price of $3.5100 per share on March 31, 2026. This valuation determined the number of shares awarded as director fee compensation.

When do John H. Caron’s new IZEA (IZEA) restricted shares vest?

The 4,274 restricted shares granted to John H. Caron vest immediately on the March 31, 2026 grant date. Immediate vesting means there is no waiting or service period before he fully owns these compensation shares.

How many IZEA (IZEA) shares does John H. Caron hold after this Form 4 filing?

After the reported grant, John H. Caron directly holds 106,415 shares of IZEA common stock. In addition, he indirectly holds 5,000 shares through the John H. Caron 1999 Family Trust, over which he has voting and investment power.

Is John H. Caron’s IZEA (IZEA) restricted stock grant an open-market transaction?

No, the transaction is a grant of restricted stock as Q1 2026 director fees, not an open-market trade. The shares were awarded at no cash cost per share to him, reflecting equity-based compensation rather than a market purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/01/2026 - 04:08 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caron John H

(Last)

(First)

(Middle)

1317 EDGEWATER DR #1880

(Street)

ORLANDO

FLORIDA

32804

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IZEA Worldwide, Inc. [ IZEA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/31/2026		A		4,274⁽¹⁾	A	$0	106,415	D
Common Stock								5,000	I	By John H. Caron 1999 Family Trust⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted Stock received for Q1 2026 director fees valued at $15,000 based on the closing market price of $3.5100 on the grant date of March 31, 2026. Award vests immediately at the grant date.

2. John H. Caron, as trustee, has voting power and investment power over the securities held by the John H. Caron 1999 Family Trust.

Remarks:

	By: /s/ Peter J. Biere as attorney-in-fact for John H. Caron	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR